Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefen Brady

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Practical Neurology|April 2, 2015
Impulse control disorder manifesting as hidden sexual self-injuryStefen Brady, Philip Duffey
Pathology|December 12, 2024
Clinicopathological collaboration in adult muscle disease: a pragmatic pathway to approach diagnostic dilemmasMonika Hofer, Stefen Brady
Neuromuscular Disorders : NMD|May 17, 2023
Scapular winging in inclusion body myositisLouisa Kent, Stefen Brady
Rheumatic Diseases Clinics of North America|October 29, 2025
Emerging Treatment Options for Inclusion Body MyositisJames B Lilleker, Stefen Brady
Rheumatology International|October 19, 2022
Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statinsFaris Khan, Stefen Brady, Anoop Kuttikat
BMJ (Clinical Research Ed.)|June 13, 2019
Subacute progressive sensorimotor symptomsAnna Francis, Robert Crossley, Stefen Brady
Autoimmunity Reviews|September 21, 2024
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategyStefen Brady, Joanna Poulton, Sylviane Muller
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2013
Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological featuresStefen Brady, Waney Squier, David Hilton-Jones
Neuromuscular Disorders : NMD|April 29, 2022
Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathyIgnacio Javier Acosta, Monika Hofer, Stefen Brady
Current Opinion in Rheumatology|September 27, 2013
Update in inclusion body myositisPedro Machado, Stefen Brady, Michael G Hanna
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Practical Neurology|April 2, 2015
Impulse control disorder manifesting as hidden sexual self-injuryStefen Brady, Philip Duffey
Pathology|December 12, 2024
Clinicopathological collaboration in adult muscle disease: a pragmatic pathway to approach diagnostic dilemmasMonika Hofer, Stefen Brady
Neuromuscular Disorders : NMD|May 17, 2023
Scapular winging in inclusion body myositisLouisa Kent, Stefen Brady
Rheumatic Diseases Clinics of North America|October 29, 2025
Emerging Treatment Options for Inclusion Body MyositisJames B Lilleker, Stefen Brady
Rheumatology International|October 19, 2022
Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statinsFaris Khan, Stefen Brady, Anoop Kuttikat
BMJ (Clinical Research Ed.)|June 13, 2019
Subacute progressive sensorimotor symptomsAnna Francis, Robert Crossley, Stefen Brady
Autoimmunity Reviews|September 21, 2024
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategyStefen Brady, Joanna Poulton, Sylviane Muller
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2013
Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological featuresStefen Brady, Waney Squier, David Hilton-Jones
Neuromuscular Disorders : NMD|April 29, 2022
Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathyIgnacio Javier Acosta, Monika Hofer, Stefen Brady
Current Opinion in Rheumatology|September 27, 2013
Update in inclusion body myositisPedro Machado, Stefen Brady, Michael G Hanna
Pageof 4